Skip to main content
. Author manuscript; available in PMC: 2017 Aug 11.
Published in final edited form as: ACS Infect Dis. 2016 Nov 2;3(1):89–98. doi: 10.1021/acsinfecdis.6b00167

Table 1.

Minimal Inhibitory Concentrations and Potentiating Activities of Top Hits

MIC WT, μM MIC WT-Pore, μM MIC ΔTolC, μM MIC ΔTolC-Pore, μM MPC4 NOV,a μM MPC4 ERY, a μM AcrAb binder ΔTolC-Porec
NSC 60339 >200 200 12.5 12.5 25 12.5 yes no
NSC 227186 >50 25 6.25 3.13 6.25 3.13 yes no
NSC 33353 200 100 12.5 12.5 1.56 3.13 yes no
NSC 305798 50 25–50 25 12.5 12.5 3.13 yes no
NSC 50651 >50 3.13 6.25 0.8 1.56 6.25 yes no
NSC 260594 >50 3.13 0.8 0.1 0.39 3.13 no yes
NSC 354844 >100 6.25 50 6.25 1.56 NAd yes no
NSC 325014 25 3.13 12.5 3.13 3.1 0.39 no no
NSC 207895 25 6.25 25 12.5 0.78 1.56 yes no
NSC 56410 12.5 3.13 1.56 1.56 0.39 NA no yes
NSC 26980 3.13 3.13 0.19 0.19 0.39 0.39 no yes
a

Potentiation in WT-Pore; NOV, novobiocin; ERY, erythromycin.

b

See Figure S5 for experimental data and KD values of selected hits.

c

Potentiation in efflux-deficient ΔTolC-Pore cells.

d

NA, no activity.